| Literature DB >> 28184976 |
Pia Sjöberg1,2, Einar Heiberg1,3,4, Pär Wingren2, Jens Ramgren Johansson5, Torsten Malm5, Håkan Arheden1,2, Petru Liuba5, Marcus Carlsson6,7.
Abstract
Four-dimensional (4D) flow magnetic resonance imaging (MRI) enables quantification of kinetic energy (KE) in intraventricular blood flow. This provides a novel way to understand the cardiovascular physiology of the Fontan circulation. In this study, we aimed to quantify the KE in functional single ventricles. 4D flow MRI was acquired in eleven patients with Fontan circulation (median age 12 years, range 3-29) and eight healthy volunteers (median age 26 years, range 23-36). Follow-up MRI after surgical or percutaneous intervention was performed in 3 patients. Intraventricular KE was calculated throughout the cardiac cycle and indexed to stroke volume (SV). The systolic/diastolic ratio of KE in Fontan patients was similar to the ratio of the controls' left ventricle (LV) or right ventricle (RV) depending on the patients' ventricular morphology (Cohen´s κ = 1.0). Peak systolic KE/SV did not differ in patients compared to the LV in controls (0.016 ± 0.006 mJ/ml vs 0.020 ± 0.004 mJ/ml, p = 0.09). Peak diastolic KE/SV in Fontan patients was lower than in the LV of the control group (0.028 ± 0.010 mJ/ml vs 0.057 ± 0.011 mJ/ml, p < 0.0001). The KE during diastole showed a plateau in patients with aortopulmonary collaterals. This is to our knowledge the first study that quantifies the intraventricular KE of Fontan patients. KE is dependent on the morphology of the ventricle, and diastolic KE indexed to SV in patients is decreased compared to controls. The lower KE in Fontan patients may be a result of impaired ventricular filling.Entities:
Keywords: CMR; Congenital heart disease; Fontan; Kinetic energy; MRI; Magnetic resonance imaging
Mesh:
Year: 2017 PMID: 28184976 PMCID: PMC5388704 DOI: 10.1007/s00246-016-1565-6
Source DB: PubMed Journal: Pediatr Cardiol ISSN: 0172-0643 Impact factor: 1.655
Patient’s characteristics
| Subject | Age at time of CMR (y) | Gender | BSA (m2) | Ventricular morphology | Type of Fontan | Diagnosis | APC | Complications | NYHA |
|---|---|---|---|---|---|---|---|---|---|
| 1 | 3 | M | 0.56 | Left | Extracardiac | Unbalanced AVSD, small LV, PA, MAPCA, right isomerism, bilateral SVC, dextrocardia. Fenestrated* | * | PLE | NYHA II |
| 2 | 7 | M | 0.82 | Left | Extracardiac | HLHS | Yes | Restrictive ASD | NYHA III |
| 3 | 4 | M | 0.68 | Right | Extracardiac | HLHS, TAPVD, bilateral SVC | Yes | PLE | NYHA IV |
| 4 | 12 | F | 1.26 | Right | Extracardiac | Hypoplastic right PA, left isomerism, interrupted IVC, dextrocardia | No | Pulmonary arteriovenous fistulas | NYHA IV |
| 5 | 4 | M | 0.72 | Right | Extracardiac | Hypoplastic aortic arch, CoA, VSD, DORV | Yes | LPA stenosis | NYHA II |
| 6 | 15 | M | 1.60 | Right | Extracardiac | DORV Taussig Bing, unbalanced AVSD, PS, TAPVD, right isomerism | Yes | APC | NYHA II |
| 7 | 17 | M | 1.72 | Right | Lateral tunnel | Single ventricle, DORV, TGA, dextrocardia | No | No | NYHA I |
| 8 | 14 | F | 1.37 | Right | Extracardiac | Single ventricle, PS, TGA, right isomerism, bilateral SVC, TAPVD | Yes | No | NYHA I |
| 9 | 13 | F | 1.36 | Left | Extracardiac | TGA, multiple VSD, hypoplastic pulm arteries | Yes | No | NYHA I |
| 10 | 29 | M | 1.72 | Left | Right atrium to PA | Tricuspid atresia | No | No | NYHA I |
| 11 | 4 | M | 0.72 | Left with long outflow tract | Extracardiac | DILV, TGA, PS, left pulm artery stenosis | No | No | NYHA II |
CMR cardiac magnetic resonance; BSA body surface area; APC aortopulmonary collaterals; NYHA New York Heart Association Functional Classification; AVSD atrioventricular septal defect; LV left ventricle; MAPCA major aortopulmonary collateral arteries; SVC superior vena cava; HLHS hypoplastic left heart syndrome; TAPVD total anomalous pulmonary venous drainage; IVC inferior vena cava; CoA coarctation of aorta; VSD ventricular septal defect; DORV double outlet right ventricle; PS pulmonary stenosis; TGA transposition of the great arteries; DILV double inlet left ventricle; PLE protein-losing enteropathy; ASD atrial septal defect; LPA left pulmonary artery
*Fenestrated extracardiac tunnel which makes the assessment of APC difficult
Characteristics and type of intervention in three patients who underwent cardiac magnetic resonance before and after intervention
| Subject | Diagnosis | Type of Fontan | Reason for intervention | Intervention |
|---|---|---|---|---|
| 4 | Hypoplastic right pulmonary artery, left isomerism, interrupted IVC, dextrocardia | Extracardiac | Pulmonary arteriovenous fistula. All liver drainage to one lung | Extracardiac conduit was converted to a Y-graft from the inferior vena cava to both pulmonary branches separately |
| 5 | Hypoplastic aortic arch, CoA, VSD, DORV | Extracardiac | Stenosis of left pulmonary artery | Dilatation and stenting of left pulmonary artery |
| 6 | DORV Taussig Bing, unbalanced AVSD, PS, TAPVD, right isomerism | Extracardiac | APC | Coiling of collaterals |
IVC inferior vena cava; CoA coarctation of aorta; VSD ventricular septal defect; DORV Double outlet right ventricle; AVSD atrioventricular septal defect; PS pulmonary stenosis; TAPVD total anomalous pulmonary venous drainage; APC aortopulmonary collaterals
Fig. 1Kinetic energy in the ventricle during the cardiac cycle. Right ventricular (RV) morphology is shown in solid line. Left ventricular (LV) morphology is shown in broken line. The left column shows Fontan patients with complications. The right column shows patients with Fontan circulation without complications and a graph showing RV and LV of the control group. Patients with APC (aortopulmonary collaterals) are marked with a star. Patient 1 had a fenestrated extracardiac conduit which makes the assessment of APC difficult
Fig. 2Ventricular kinetic energy (KE) in a Fontan patient superimposed on CMR images to visualize the anatomical location of KE. The upper panel shows an oblique sagittal view in systole (a) and diastole (b). Systolic peak KE can be seen in a ventricular septal defect leading the blood to the aorta. Diastolic peak KE is located from the atrioventricular valve into the ventricle. The lower panel visualizes KE in an oblique transversal view in the same patient in systole (c) and diastole (d). AAo ascending aorta; VSD ventricular septal defect; V ventricle; A atrium; AV valve atrioventricular valve; AoV aortic valve; DAo descending aorta; T lateral tunnel
Fig. 3Kinetic energy (KE) indexed to stroke volume. The left column shows peak KE during systole and the right column peak KE during diastole. a and b shows all Fontan patients and the left ventricle in the control group. c and d shows Fontan patients with LV morphology and the left ventricle in the control group. e and f shows Fontan patients with RV morphology and the right ventricle in the control group. Error bars show mean ± SD
Kinetic energy indexed to stroke volume, body surface area, and cardiac index in Fontan patients compared to healthy controls, divided into type based on ventricular morphology
| Ventricular morphology | Fontan patients | Controls | |
|---|---|---|---|
| Left ventricle | EDVI, ml/m2 | 102 ± 42 | 101 ± 11 |
| ESVI, ml/m2 | 60 ± 29 | 43 ± 8 | |
| EF, % | 43 ± 6 | 57 ± 5 | |
| CO, l/min | 3.7 ± 2.4 | 6.5 ± 1.2 | |
| CI, l/min/m2 | 4.0 ± 1.5 | 3.3 ± 0.4 | |
| Peak systolic KE/SV, mJ/ml | 0.022 ± 0.004 | 0.048 ± 0.012 | |
| Peak diastolic KE/SV, mJ/ml | 0.033 ± 0.007 | 0.058 ± 0.010 | |
| Peak systolic KE/BSA, mJ/m2 | 0.56 ± 0.20 | 2.57 ± 0.60 | |
| Peak diastolic KE/BSA, mJ/m2 | 1.42 ± 0.73 | 3.18 ± 0.62 | |
| Peak systolic KE/CI, mJ/(l/min/m2) | 0.37 ± 0.18 | 1.55 ± 0.38 | |
| Peak diastolic KE/CI, mJ/(l/min/m2) | 0.51 ± 0.15 | 1.93 ± 0.48 | |
| Right ventricle | EDVI, ml/m2 | 87 ± 20 | 96 ± 17 |
| ESVI, ml/m2 | 52 ± 13 | 40 ± 10 | |
| EF, % | 39 ± 7 | 59 ± 6 | |
| CO, l/min | 3.4 ± 2.0 | 6.8 ± 1.5 | |
| CI, l/min/m2 | 2.9 ± 1.0 | 3.4 ± 0.5 | |
| Peak systolic KE/SV, mJ/ml | 0.043 ± 0.018 | 0.074 ± 0.014 | |
| Peak diastolic KE/SV, mJ/ml | 0.025 ± 0.012 | 0.034 ± 0.007 | |
| Peak systolic KE/BSA, mJ/m2 | 0.78 ± 0.51 | 4.04 ± 0.87 | |
| Peak diastolic KE/BSA, mJ/m2 | 0.96 ± 0.54 | 1.94 ± 0.70 | |
| Peak systolic KE/CI, mJ/(l/min/m2) | 0.79 ± 0.58 | 2.36 ± 0.65 | |
| Peak diastolic KE/CI, mJ/(l/min/m2) | 0.44 ± 0.31 | 1.11 ± 0.38 |
RV right ventricle; LV left ventricle; EDVI end-diastolic volume index; ESVI end-systolic volume index; EF ejection fraction; CO cardiac output; CI cardiac index; KE kinetic energy; SV stroke volume; BSA body surface area; CI cardiac index
Fig. 4KE throughout the cardiac cycle in three patients before and after surgical or percutaneous intervention. Details of the intervention are listed in Table 2. Heart rate (beats/minute) pre-intervention/post-intervention was in patient 4: 103/87, patient 5: 85/83, patient 6: 63/80